These intriguing findings propose an inverse role for EPLIN to other cancer type, such as breast cancer24 and colorectal cancer23 and is of significant interest to researchers who are researching for novel therapeutic targets for pancreatic cancer. The gene discussed is LIMA1; the disease is familial pancreatic carcinoma.